ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20220017604A1
SERIAL NO

17232796

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies or antigen-binding fragments that are useful for treating coronavirus infections (e.g., COVID-19 caused by SARS-CoV-2). The present invention also relates to various pharmaceutical compositions and methods of treating coronavirus using the antibodies or antigen-binding fragments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WASHINGTON UNIVERSITYONE BROOKINGS DRIVE ST LOUIS MO 63130

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Al, Soussi Wafaa St. Louis, US 1 0
Boon, Adrianus St. Louis, US 1 0
Case, James Brett St. Louis, US 2 0
Diamond, Michael St. Louis, US 25 99
Ellebedy, Ali St. Louis, US 5 0
Fremont, Daved St. Louis, US 14 42
McCluskey, Andrew Holden, US 7 1
Negron, Christopher Worcester, US 1 0
Schmitz, Aaron St. Louis, US 40 514
Turner, Jackson St. Louis, US 5 3
Whelan, Sean St. Louis, US 25 315
Zhao, Haiyan St. Louis, US 20 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation